KR101887098B1 - System for automaticmanagement of insulin - Google Patents

System for automaticmanagement of insulin Download PDF

Info

Publication number
KR101887098B1
KR101887098B1 KR1020180026028A KR20180026028A KR101887098B1 KR 101887098 B1 KR101887098 B1 KR 101887098B1 KR 1020180026028 A KR1020180026028 A KR 1020180026028A KR 20180026028 A KR20180026028 A KR 20180026028A KR 101887098 B1 KR101887098 B1 KR 101887098B1
Authority
KR
South Korea
Prior art keywords
insulin
time
digital
consumption time
amount
Prior art date
Application number
KR1020180026028A
Other languages
Korean (ko)
Other versions
KR20180026712A (en
Inventor
이진용
Original Assignee
주식회사 필로시스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 필로시스 filed Critical 주식회사 필로시스
Priority to KR1020180026028A priority Critical patent/KR101887098B1/en
Publication of KR20180026712A publication Critical patent/KR20180026712A/en
Application granted granted Critical
Publication of KR101887098B1 publication Critical patent/KR101887098B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06QDATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q20/00Payment architectures, schemes or protocols
    • G06Q20/30Payment architectures, schemes or protocols characterised by the use of specific devices
    • G06Q20/32Payment architectures, schemes or protocols characterised by the use of specific devices using wireless devices
    • G06Q20/322Aspects of commerce using mobile devices [M-devices]
    • G06Q20/3223Realising banking transactions through M-devices
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06QDATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q20/00Payment architectures, schemes or protocols
    • G06Q20/38Payment protocols; Details thereof
    • G06Q20/382Payment protocols; Details thereof insuring higher security of transaction
    • HELECTRICITY
    • H04ELECTRIC COMMUNICATION TECHNIQUE
    • H04MTELEPHONIC COMMUNICATION
    • H04M1/00Substation equipment, e.g. for use by subscribers; Analogous equipment at exchanges
    • H04M1/72Substation extension arrangements; Cordless telephones, i.e. devices for establishing wireless links to base stations without route selecting
    • H04M1/725Cordless telephones
    • H04M1/72519Portable communication terminals with improved user interface to control a main telephone operation mode or to indicate the communication status
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M2005/14208Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/35Communication
    • A61M2205/3576Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3584Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/58Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/581Means for facilitating use, e.g. by people with impaired vision by audible feedback
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/58Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/583Means for facilitating use, e.g. by people with impaired vision by visual feedback

Abstract

The present invention relates to a digital insulin pen including a communication device, the method comprising the steps of: (S10) transmitting information about a storage amount of insulin to a smartphone; The smart phone stores information on the amount of stored insulin (S20); When the insulin is injected into the user using the digital insulin pen, the communication device of the digital insulin pen transmits information on the insulin injection amount and the injection time to the smartphone (S30); The smartphone stores information on the insulin injection amount and the injection time (S40); The smartphone calculates a predicted consumption time (S50) in which the insulin storage amount is estimated to be consumed according to the insulin injection amount and the insulin injection amount when the steps S30 and S40 are repeated n times; And providing the user with information for supplementing insulin when the predicted consumption time arrives, wherein the smartphone is configured to consume the insulin storage amount, insulin infusion amount, infusion time, and insulin storage amount And an application program capable of predicting and calculating the time for which the insulin is administered.

Description

System for automatic management of insulin < RTI ID = 0.0 >

The present invention relates to an insulin automatic management system, and more particularly, to an insulin automatic management system that accurately predicts insulin consumption of a digital insulin pen and provides insulin management convenience to a user.

Diabetes mellitus is divided into insulin dependent diabetes mellitus (type 1 diabetes mellitus) and non-insulin dependent diabetes mellitus (type 2 diabetes mellitus). Type 1 diabetes is a type of diabetes mellitus that is caused by the inability of the human body to produce insulin normally due to genetic influences, resulting in diabetes mellitus. Type 2 diabetes mellitus is mainly expressed in obese patients after age 40 and the pancreas secretes insulin, The insulin secretion can not be effectively utilized, resulting in an increase in blood glucose. Type 1 diabetes and type 2 diabetes are common in that they require the administration of insulin injections to the human body for treatment.

Recently, diabetic patients use the easy-to-use digital insulin pen to inject insulin into the human body. A digital insulin pen is composed of a main body, an insulin cartridge, and an insulin pen needle, and has an advantage that an insulin injection amount can be electronically controlled and a necessary amount can be obtained from other sources. However, the conventional digital insulin pen has a problem that insulin consumption can not be precisely known, so that extra insulin cartridges may be prepared, or insulin may be injected into the insulin by a less amount than necessary.

Korean Patent Publication No. 2005-0039326 discloses an insulin pump connected to a mobile communication terminal capable of measuring blood glucose and transmitting measured blood glucose information to a blood sugar management server, An external input port for receiving insulin dose information corresponding to the measured blood glucose information from the communication terminal; A memory for storing the insulin dose information; A key input unit for receiving an electric signal before and after each meal and before sleeping; A controller for extracting the insulin dose information from the memory corresponding to the key signal of the key input unit and generating a control code according to the insulin dose information; And a motor driving driver for driving a soft motor to supply insulin in response to the control code. The insulin pump is coupled to a mobile communication terminal capable of measuring blood glucose. However, there is a problem that the insulin pump coupled with the mobile communication terminal capable of measuring the blood glucose must always live with the needle inserted in the skin, the price is high, and side effects may occur due to the device failure.

The present inventor has proposed a method for automatic processing of test strip purchase information that can accurately check the number of times of measurement of biometric information in Korean Patent No. 10-1323683 entitled " Method for Automatic Processing of Test Strip Purchase Information " We have come up with an automatic insulin management system that can accurately calculate consumption.

KR 10-2005-0039326 A

It is an object of the present invention to provide an insulin automatic management system that accurately predicts insulin consumption of a digital insulin pen and provides insulin management convenience to the user.

Another object of the present invention is to provide an insulin automatic management system capable of accurately supplying necessary insulin at the time of consumption of insulin.

The above and other objects of the present invention can be achieved by the present invention described below.

In an automatic insulin automatic management system according to an embodiment of the present invention, the digital insulin pen including the communication device transmits information about the insulin storage amount to a smartphone (S10); The smart phone stores information on the amount of stored insulin (S20); When the insulin is injected into the user using the digital insulin pen, the communication device of the digital insulin pen transmits information on the insulin injection amount and the injection time to the smartphone (S30); The smartphone stores information on the insulin injection amount and the injection time (S40); The smartphone calculates a predicted consumption time (S50) in which the insulin storage amount is estimated to be consumed according to the insulin injection amount and the insulin injection amount when the steps S30 and S40 are repeated n times; And providing the user with information for supplementing insulin when the predicted consumption time arrives (S60), wherein the smartphone stores the insulin storage amount, the insulin infusion amount, the infusion time, and the insulin storage amount And an application program capable of predicting and calculating the consumed time.

Here, the automatic insulin management system may further include a step (S55) of correcting a difference between the actual consumption time at which the insulin storage amount is completely consumed and the predicted consumption time between steps S50 and S60.

If it is determined in step S55 that the predicted consumption time is shorter than the actual consumption time, an increased correction value is applied to the process of calculating the predicted consumption time in step S50.

If the predicted consumption time is longer than the actual consumption time, the reduced correction value is applied to the process of calculating the predicted consumption time in step S55.

The step S60 may further include providing a visual or auditory warning to the user.

The step S60 may further include a step in which the smartphone automatically makes an insulin payment using the payment information of the predetermined insulin.

The present invention provides an insulin automatic management system that accurately predicts insulin consumption of a digital insulin pen to provide insulin management convenience to a user and can accurately supply necessary insulin at the time of consumption of insulin.

1 is a flowchart schematically showing an automatic insulin management system according to an embodiment of the present invention.

The above objects, features, and advantages of the present invention will become more apparent by describing in detail preferred embodiments of the present invention with reference to the accompanying drawings. The following detailed description is not to be taken in a limiting sense, and the scope of the invention is to be limited only by the appended claims, along with the full scope of equivalents to which the claims are entitled.

Hereinafter, preferred embodiments of the present invention will be described in detail with reference to the accompanying drawings.

1 is a flowchart schematically showing an automatic insulin management system according to an embodiment of the present invention.

As shown in FIG. 1, an automatic insulin management system according to the present invention includes a digital insulin pen including a communication device, a step S10 of transmitting information on the amount of stored insulin to a smartphone; The smart phone stores information on the amount of insulin stored in the memory; In the case of injecting insulin into the user using the digital insulin pen, the communication device of the digital insulin pen transmits information on the insulin injection amount and the injection time to the smartphone in step S30. The smartphone stores information on the insulin injection amount and the injection time in step S40; The smartphone calculates the predicted consumption time that the insulin storage amount is expected to be consumed according to the insulin injection amount and the injection time when the steps S30 and S40 are repeated n times; And the step S60 of providing the user with additional information for purchasing insulin when the predicted consumption time arrives.

Here, the smartphone includes an application program capable of predicting and calculating the insulin storage amount, insulin infusion amount, infusion time, and insulin storage time.

Specifically, the automatic insulin management system according to the present invention performs a step S10 in which the digital insulin pen including the communication device transmits information on the insulin storage amount to the smartphone. Since the digital insulin pen can store information on the amount of insulin stored in the insulin cartridge inserted in the internal storage device, it is possible to easily transmit information on the insulin storage amount to the smartphone. After step S10, the smart phone performs step S20 in which information on the amount of insulin stored in the digital insulin pen is stored in the storage device of the smart phone. Thereafter, when the user injects insulin into the body using the digital insulin pen, the communication device of the digital insulin pen performs step S30 of transmitting information on the amount of insulin and the injection time to the smartphone. The digital insulin pen in step S30 can accurately measure the insulin injection amount and the injection time using an internal sensor and a timer. The smart phone then performs step S40 of storing information on the amount of insulin injected and the time of injection transmitted from the digital insulin pen.

After step S30 and step S40 are repeated n times, the smartphone proceeds to step S50 of calculating the predicted consumption time, which is predicted to consume the insulin storage amount according to the insulin injection amount and the injection time. For example, if insulin storage in an insulin cartridge is 300 units, the first dose and the infusion time are 10 units each, June 1, 2016 at 8:00 a.m .; Assuming that the second injection amount and the injection time are 20 units each, and June 1, 2016 at 6:00 pm, the smartphone consumes 30 units per 10 hours in step S50, and the rate of 3 units / hr is insulin consumption Calculated by rate, the predicted consumption time for insulin is counted from 100 hours to 8:00 am on June 1, 2016. In this process, the smartphone may inform the user of the results of the counting by hour, and inform the user at the scheduled time of replacing the insulin cartridge at noon on June 5, 2016, which is 100 hours after 8:00 am on June 1, .

Since the average value of the data of the insulin injection amount and the injection time is set as the insulin consumption rate for the predicted consumption time in the step S50 of the present invention, the predicted consumption time by the automatic evolution algorithm However, in order to correct the difference between the actual consumption time and the predicted consumption time of the insulin more accurately, the automatic insulin management system of the present invention may reduce the actual consumption time of the insulin storage amount between the steps S50 and S60 And correcting the difference between the actual consumption time and the predicted consumption time.

Specifically, if it is determined in step S55 that the predicted consumption time is shorter than the actual consumption time, the predicted consumption time may be substantially increased by applying an increased correction value to the estimated consumption time in step S50, If the actual consumption time is longer than the actual consumption time, the reduced correction value may be applied to calculate the predicted consumption time in step S50 so that the predicted consumption time may be corrected to be less than the actual consumption time.

After step S50, the smart phone goes through step S60 to provide the user with additional information for purchasing additional insulin when the predicted consumption time arrives. Here, the step S60 may further comprise providing a visual or auditory warning to the user. In step S60, the smartphone may further include automatic payment of insulin using the payment information of the predetermined insulin.

Although the preferred embodiments of the present invention have been described, the present invention is not limited to the specific embodiments described above. It will be apparent to those skilled in the art that various modifications and variations can be made in the present invention without departing from the spirit or scope of the appended claims, And equivalents should also be considered to be within the scope of the present invention.

Claims (7)

  1. Receiving information on a first insulin storage amount included in a first insulin cartridge inserted into the digital insulin pen from a digital insulin pen;
    Receiving information on an insulin dose and an insulin dose from the digital insulin pen when the insulin is injected using the digital insulin pen;
    Calculating a first predicted consumption time that is predicted to consume the first insulin storage amount included in the first insulin cartridge;
    Providing the first predicted consumption time to a user;
    Calculating a difference between the calculated first predicted consumption time and a first actual consumption time when the first insulin storage amount included in the first insulin cartridge is actually consumed;
    The method comprising: receiving information on an amount of insulin and an injection time from the digital insulin pen every time insulin contained in the second insulin cartridge inserted into the digital insulin pen is injected; Calculating an insulin consumption rate using an injection amount and an injection time and calculating a second predicted consumption time of insulin contained in the second insulin cartridge using the insulin consumption rate; And
    Correcting the second predicted consumption time based on the difference between the calculated first predicted consumption time and the first actual consumption time
    Lt; RTI ID = 0.0 > insulin < / RTI >
  2. The method of claim 1, wherein the step of receiving information on the amount and time of insulin injection from the digital insulin pen comprises:
    The method comprising: receiving information on the amount and time of insulin injection from the digital insulin pen every time insulin is injected using the digital insulin pen; and calculating an insulin consumption rate using the amount of insulin injected and the time of injection Steps to calculate
    Lt; / RTI >
    The step of calculating the first predicted consumption time
    Calculating the first predicted consumption time using the insulin consumption rate
    Lt; RTI ID = 0.0 > insulin < / RTI >
  3. delete
  4. 2. The method of claim 1, wherein the correcting the second predicted consumption time comprises:
    Applying the increased correction value when calculating the second predicted consumption time when the first predicted consumption time is shorter than the first actual consumption time
    Lt; RTI ID = 0.0 > insulin < / RTI >
  5. 2. The method of claim 1, wherein the correcting the second predicted consumption time comprises:
    Applying the reduced correction value when calculating the second predicted consumption time if the first predicted consumption time is longer than the first actual consumption time
    Lt; RTI ID = 0.0 > insulin < / RTI >
  6. A computer program stored in a medium for executing the method of any one of claims 1, 2, 4, and 5 in combination with hardware.
  7. In digital insulin pens,
    An inserting portion into which an insulin cartridge including insulin can be inserted;
    Wherein when the insulin cartridge is inserted into the inserting unit, information on the amount of insulin stored in the insulin cartridge is transmitted to an external device, and when insulin contained in the insulin cartridge is injected, To the external device;
    A sensor for measuring an amount of insulin injected every time the insulin contained in the insulin cartridge is injected;
    Whenever the insulin contained in the insulin cartridge is injected, a timer for measuring the insulin infusion time
    Lt; / RTI >
    Calculating a first predicted consumption time that the first insulin storage amount included in the first insulin cartridge is expected to be consumed,
    Calculating a difference between the calculated first predicted consumption time and a first actual consumption time in which the first insulin storage amount included in the first insulin cartridge is actually consumed,
    Receiving information on the amount and time of insulin injection from the digital insulin pen every time the insulin contained in the second insulin cartridge inserted into the digital insulin pen is injected,
    Calculating an insulin consumption rate using the amount and time of injection of the plurality of received insulin,
    Calculating a second predicted consumption time of insulin contained in the second insulin cartridge using the insulin consumption rate,
    Based on a difference between the calculated first predicted consumption time and the first actual consumption time, corrects the second predicted consumption time
    Digital Insulin Pen.
KR1020180026028A 2018-03-05 2018-03-05 System for automaticmanagement of insulin KR101887098B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020180026028A KR101887098B1 (en) 2018-03-05 2018-03-05 System for automaticmanagement of insulin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020180026028A KR101887098B1 (en) 2018-03-05 2018-03-05 System for automaticmanagement of insulin

Publications (2)

Publication Number Publication Date
KR20180026712A KR20180026712A (en) 2018-03-13
KR101887098B1 true KR101887098B1 (en) 2018-08-13

Family

ID=61660953

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020180026028A KR101887098B1 (en) 2018-03-05 2018-03-05 System for automaticmanagement of insulin

Country Status (1)

Country Link
KR (1) KR101887098B1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100567837B1 (en) 2003-10-24 2006-04-05 케이제이헬스케어 주식회사 Insulin pump combined with mobile which detects a blood glucose, network system for transmitting control imformation of the insulin pump
US7740612B2 (en) * 2007-07-27 2010-06-22 Milestone Scientific, Inc Self-administration injection system
KR101162147B1 (en) * 2010-05-06 2012-07-05 주식회사 우영메디칼 Method for managing history of medicine injection
KR101583070B1 (en) * 2014-03-21 2016-01-07 주식회사 인와이저 Controlling system of blood sugar using integrated data management platform

Also Published As

Publication number Publication date
KR20180026712A (en) 2018-03-13

Similar Documents

Publication Publication Date Title
US7941200B2 (en) System and method for determining drug administration information
EP1955240B1 (en) Method for manual and autonomous control of an infusion pump
US7734323B2 (en) Correction factor testing using frequent blood glucose input
EP2260423B1 (en) Apparatus for optimizing a patient's insulin dosage regimen
US8377031B2 (en) Closed loop control system with safety parameters and methods
US9392969B2 (en) Closed loop control and signal attenuation detection
US8777895B2 (en) System and method for authorized medication delivery
CA2612714C (en) Fully automated control system for type 1 diabetes
CA2634516C (en) Method of operating a medical device and at least a remote controller for such medical device
CA2634835C (en) Systems and methods to pair a medical device and a remote controller for such medical device
US9136939B2 (en) Graphical user interface pertaining to a bolus calculator residing on a handheld diabetes management device
US20170068533A1 (en) Systems and methods for updating a medical device
JP4987121B2 (en) Closed loop / semi-closed loop therapy correction system
US20080312512A1 (en) Methods to pair a medical device and at least a remote controller for such medical device
US9795738B2 (en) Intelligent therapy recommendation algorithim and method of using the same
ES2670420T3 (en) Fluid management device and its operating methods
EP2537110B1 (en) Closed-loop glucose control startup
ES2681895T3 (en) Glucose control method and system to monitor the individual metabolic response and to generate a nutritional response
JP2014204998A (en) Model predictive method and system for controlling and supervising insulin infusion
EP1834266B1 (en) System and method for determining insulin bolus quantities
US20070167919A1 (en) Chemical liquid injection system
US9522232B2 (en) Data storage for an infusion pump system
JP2011515112A (en) Method for selecting a bolus dose in a drug delivery device
US20080200870A1 (en) System for guiding a user during programming of a medical device
US8622988B2 (en) Variable rate closed loop control and methods

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
E902 Notification of reason for refusal
E90F Notification of reason for final refusal
E701 Decision to grant or registration of patent right